Abstract
Only one case of vasculitis associated with sorafenib has been reported, and the authors now present the first reported case of annular leukocytoclastic vasculitis (LCV) linked to sorafenib administration.
| Original language | English |
|---|---|
| Pages (from-to) | 697-698 |
| Number of pages | 2 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 9 |
| Issue number | 6 |
| State | Published - Jun 2010 |
| Externally published | Yes |